Disruption of the PIKfyve/Fig4/Vac14 complex drives ULK1-dependent trafficking of PI4KIIα and ATG9A to lysosomes, elevating lysosomal PI(4)P to promote membrane repair and induce mitochondrial fragmentation with increased respiration
0:00Welcome to Base by Base, the paper cast that brings Genomics to you wherever you are. Thanks for listening, and don't forget to follow and rate us in your podcast app. We are launching into a really fascinating deep dive today.
0:11We really are It's one that tackles, well, a fundamental riddle in cellular biology. The paradox of PI5. Exactly. This is a story about a single molecular complex that seems to be absolutely essential for life.
0:23Yet, and this is the core of it. Its temporary disruption holds profound therapeutic promise for some really deadly neurological diseases. Okay, let's unpack this because the core puzzle here is, uh, it's truly astonishing.
0:37We're talking about the PIK 5 Fig 4 VAC 14 complex. Now, genetic notations that disable this complex. They cause devastating chronic neurodegenerative conditions. We're talking severe forms of ALS and Charco Marie tooth syndrome.
0:51Precisely. Chronic loss equals devastating disease. simple as that. But, and here's a contradiction, pharmacologically blocking that exact same complex. Acutely, you know, in a short burst. That's emerging as a cutting edge therapeutic strategy in preclinical models of those very same diseases.
1:08It's completely counterintuitive. How can losing something cause a disease, but intentionally removing it for a moment be the cure? It's like breaking a car's brake pedal to make it run faster. It doesn't make sense on the surface.
1:22Well, it suggests we're not looking at a simple loss of function. We're looking at something much more complex, a sort of hidden cellular safety mechanism. A survival switch that's held in check under normal circumstances.
1:34When you disrupt the PIK5 complex, you're not just breaking something, you're releasing a break. You're triggering this cascading protective response. But that response, if it's sustained for too long might be what causes the eventual burnout in disease.
1:49That's the hypothesis. So our mission in this deep dive is to trace that response. What is this molecular safety switch and how does it manage to rescue the most vulnerable parts of the cell, the mitochondria and the lysosomes in the short term?
2:02Because we know when neurons fail in these neurodegenerative disorders, their internal infrastructure, their recycling centers and their powerhouses. They're almost always compromised. That's a common feature.
2:13That's right. So today we're celebrating the work that provided this incredible mechanistic resolution. We really want to acknowledge the key contributors to this insightful research. Candace Konchukian, Maria Casas, Rosie Dixon, and Eamon J. Dixon at the University of California Davis.
2:30Their work focused on understanding how phosphonocetide metabolism. So a very particular type of fat signaling coordinates both the repair of the cells maintenance system and the health of its power grid.
2:41It's a beautifully complex piece of cellular choreography. It really is. So to set the stage, let's start with the lysosomes. You can think of them as the cell's main recycling and demolition group. They maintain cellular homeostasis or balance by breaking down waste, worn out organelles and pathogens, using over 50 different hydrolytic enzymes.
3:01And their integrity is everything. If the lysosomal membrane is damaged, those digestive enzymes leak out and start, well, destroying the rest of the cell, it's catastrophic. Absolutely. And we see this dysfunction, this integrity failure, the licosum, linked not just to ALS, but to autoimmune diseases, cancer, a whole host of neurodegenerative conditions.
3:22And that's where the lipids come in. That's where lipids come in, specifically, phosphinocetines, or PIs. These are small, low abundance signaling lipids, but they are absolutely pivotal. They sit on the membrane surface and act as traffic cops.
3:34You know directing proteins and vesicles to the right location at the right time. And this PIK5 complex, PIK5, figure 4 and VAC 14, it's the master regulator of the system at the Lysosum. It is. Its main job is to generate a very specific low abundance lipid called PI 3 5P right there on the lysosomal surface.
3:53So PI35P is basically the cellular signal for all is well. Everything is operating normally. That's a great way to put it. So when you have inherited loss of function mutations in FIG for a VAC 14, the complex collapses, PI35PLOs just plummet, and you get these chronic, severe neurological disorders we mentioned.
4:13The cell loses its fundamental sense of balance. It does. But, as we said, acute pharmacological inhibition of PIQ5 also causes PI35P levels to drop. And yet, these inhibitors, like Apilomod, are showing promise and mitigating disease progression in ALS models.
4:31It's the ultimate therapeutic contradiction. So we need to know what protective mechanism is being released when that brake is lifted, and more importantly, how we can harness it. And that's why the methodology here was so insightful.
4:43The researchers recognized they couldn't just study the disease state. They had to study the intervention state and compare them side by side. They used a brilliant parallel approach. So on one side, they modeled the chronic disease using genetic CRISPR knockouts of figure 4 and back 14.
4:56Long-term devastating scenario. Exactly. And on the other side, On the other side, they model the acute therapeutic intervention by using these highly selective PIK5 inhibitors, like YM Duoisix 236 and Pillomod.
5:11This let them isolate the rapid immediate response pathways that the cell throws into action, you know, before the system has time to fully collapse. And to map the switch, they deployed a, well, a really comprehensive suite of advanced tools.
5:23I think this is where the rigor of the study just shines through. I agree. They didn't just look at one element. They looked at bulk, chemistry, location, signaling activity, and functional output all at once.
5:34So where do they start? They started with UPLC, MSMS, lipidomics. This technique gave them the bulk measurements of all the phosphatyl known cell monophosphates, the PIPs, and it showed the major changes in the overall cellular pool.
5:47And that's where they 1st saw this significant shift in a highly abundant lipid PI4P. Right. But the bulk data doesn't tell you where it is. So they complemented that with high resolution microscopy using these specialized fluorescent biosensors.
6:00The P4MYFP sensor. That's the one. This sensor literally lights up when it binds to PI4P. So it allowed them to track the exact subcellular location of this signaling lipid in real time. Okay, so they know it's changing and where it's going.
6:15Then they had to look at the signaling cascade itself. Hmm. They use Brett Biosensors and Western blots to confirm that PIC 5 inhibition was loosening the regulatory brake on MTORC1 activity, which is a master growth and metabolism regulator.
6:30They saw a modest but confirmed reduction about 25% in the phosphoreation of key MTORC one targets. And finally, they measured the functional outcomes. This is the so what part of the paper? Absolutely.
6:43They use something called the LMA Challenge. It's a toxin that specifically damages lysosomal membranes, and they combine that with Galactin 3 recruitment to quantify exactly how well the cell could repair itself.
6:53And for the energy state? Critically, they use Seahorse XF 96 analysis. This gives you these real-time comprehensive readouts of mitochondrial functions, so they're ensuring they weren't just looking at proteins, but at the actual metabolic health of the cell.
7:05Okay, so let's trace the dominoes. This is where we resolve the paradox. The acute disruption of the PI5 complex, it activates a rapid interconnected cellular survival cascade. The 1st most critical step is what they call the phosphonocetite shift.
7:22When PI5 is inhibited, the cell loses its PI5 P shore, all clear signal. But simultaneously, the team observed a rapid, almost instantaneous redistribution of PI 4P. So this PI4P, it drained away from the Transgolgi network, the TGN, where usually hangs out.
7:41And it rapidly accumulated on the damaged lysosomal membranes. Wait, so the cell isn't just losing a lipid. actively substituting it with a different one right at the site of damage, it's swapping out one flag for another.
7:51Exactly. It's changing the entire lipid signature of the lysosomal membrane. And this new lipid signature, that's the starting gun for the whole adaptive repair cascade. So what's the very 1st domino to fall on that cascade?
8:04The loss of PI35P urus causes the master regulator, MTOR, to dissociate from the licysum. Now, this modest drop in MT or activity is sufficient to relieve the inhibitory brake it usually holds on another key kines.
8:18ULK1. And ULK1 is a major player in autophagy, the cellular self-cleaning process. So when that brake is lifted, ULK one activates and it immediately gets busy. And this is the critical step the study revealed.
8:30Activated ULK1 doesn't just trigger some general cleaning. It drives highly specific trafficking. It actually commandeers the cellular machinery to promote the movement of the PI4P synthesizing enzyme, PI4KE, along with a membrane protein code, ATG9A.
8:46So it rushes this entire PI4P factory directly from the TGN right to the damaged license sum. Precisely. The cell sense is damage. It lists the brake with MTOR and ULK1, and then ULK1 acts as the emergency dispatcher.
8:58Sending the PI4KI enzyme to manufacture the new PI4P flag right where it's needed most. And they prove this, right, by inhibiting ULK1. They did. And when they did, the accumulation of PI for KIE on the PI4P on the licensum just stopped.
9:11The link is undeniable. So now the lysosomal membrane is suddenly flush with PI4P. What happens next? Now it can activate its 2 major protective responses, and it does this simultaneously. Okay, let's focus on the membrane repair first.
9:25How does PI4P actually patch the hole? It's through a process called the phosphonocetide initiated membrane tethering and transfer pathway or the PITT pathway. Think of the new PI4P on the Lysosum as a specific docking signal.
9:38It attracts lipid transfer proteins like OSBP and ORP 9 to these crucial contact points between the Lysosome and the endoplasmic reticulum or ER. And the ER is the largest membrane network in the cell.
9:51just full of resources. So the PI4P flag is essentially calling over the ER to help out. It's a direct call for help. The recruited lipid transfer proteins facilitate the rapid exchange of vital stabilizing lipids, specifically cholesterol and phosphatidilcerine, moving them directly from the ER onto that compromised lysosomal membrane.
10:10It's a physical reinforcement job, fast and localized. And the functional result was crystal clear. The cells that had PIK 5 inhibited were significantly protected from the membrane damage induced by that Eloaine as toxin, they maintained proper lysosomal acidification.
10:27They got a quick adaptive repair job done. But wait, there's a parallel function happening at the same time, and this is maybe even more surprising. It's how this pathway hyper boosts the cell's energy supply, the mitochondria.
10:37So how does patching the lysosome also manage to rev up the cell's engine? It's all tied back to physical proximity and communication. The researchers found that PIK5 inhibition didn't just increase ER license and contacts.
10:52It dramatically increased the frequency of physical three-way contact sites. Between the ER, the Lysosum, and the mitochondria. Yes. These three-way contacts increase by about 2.5 fold. Wow, so these are critical integrated communication hubs that are forming rapidly across the cell.
11:08And the key protein recruited to these hubs in the ULK1 dependent manner is ORP1L. This pathway, situated right at the junction, then promotes the recruitment of the key mitochondrial fish and protein, DRP1.
11:20Fission, meaning splitting. So JRP1 activation causes extensive mitochondrial fragmentation, splitting the long, healthy mitochondria into smaller, separated pieces. But wait a second, that sounds counterintuitive.
11:33Isn't mitochondrial fragmentation usually a sign that a cell is under extreme distress or maybe the 1st step towards cell death? That is often the case, yes, in product pathology. However, in this acute adaptive scenario, fragmentation is beneficial.
11:49And the functional assays confirmed this. The real time functional assays using the seahorse machine confirmed it, without a doubt. The fragmentation was associated with a significant enhancement in all parameters of mitochondrial respiration.
12:02All parameters. You're talking basal respiration, maximal respiratory capacity, proton leak, ATP coupled respiration. Every single measure of metabolic efficiency was boosted. That's the cellular equivalent of installing a turbocharger.
12:15The cell is switching to a higher energy setting to deal with the immediate stress. It's an adaptive way to maximize energy efficiency and production under duress, likely by optimizing the surface area for exchange across those contacts sites.
12:27So we've gone from a single protein complex disruption to a full-scale cellular mobilization. featuring accelerated membrane repair and an immediate hyperfunctional energy boost. So this is the reconciliation for the paradox, isn't it?
12:40The PIK5 FIG4VAC 14 complex is essentially a regulatory break under basal healthy conditions. It keeps this robust ULK one dependent adaptive pathway suppressed when it's not needed. Exactly. Acute pharmacological inhibition lists this break, providing the short-term side of protective effects, the enhanced repair, the immediate energy booth.
13:03It could be therapeutically beneficial. It's a powerful but temporary fix. But if this mechanism is so robust, where does the chronic disease state the genetic loss of figure 4 or FAC 14 fail? Why doesn't this adaptive system save those cells long term?
13:16Well, that's the core implication here. Well, the adaptive response is powerful. It is also incredibly resource intensive. Chronic genetic disruption means this brake is permanently off. So it's constantly demanding high-level repair and sustain hyperfunctionality.
13:31Right. The cell is perpetually running its turbocharger, and eventually it just exhausts its capacity. That leads to the long-term debilitating pathology we see in patients. So the study identifies the mechanism, and in doing so, it frames the disease as a result of system overreach, rather than just the simple loss of PI35PO.
13:49And it also identifies the physical basis of this coordination. Those three-way contact sites between the ER, lysosomes, and mitochondria. These are critical communication hubs. The newly accumulated lysosomal PI 4P transfer signals and likely lipids to regulate mitochondrial dynamics via RP1L and DRP1.
14:09It links repair and energy in a single place. And the broader implications suggest PIK 5 modulation is a highly sophisticated, multifaceted approach. I mean, beyond just repair and energy, this inhibition also triggers TFEB nuclear translocation.
14:23Which is a master switch for creating new license altogether. Right. And there's supporting data showing that PIK 5 inhibition also helps mitigate the spread of toxic protein aggregates like ossinucleane and tau in other disease models.
14:34It truly is a cellular system reset switch. But the researchers were also careful to note the limitations. They pointed out that their lipidomics couldn't fully differentiate all the similar PI isomers, and that the average suppression of MTRC one they measured, that 25% figure, seemed relatively modest compared to the profound functional changes they observed.
14:57And that suggests that the signaling regulation isn't just about Bork activity, but about ultra sensitive localized regulation, right of those membrane contact points. Future work really needs to drill down on these micro regulations.
15:11Absolutely The regulatory details are everything if we want to turn this into a safe drug. If we can precisely control that regulatory brake releasing it just enough for just the right amount of time. We could maximize the protective short-term benefits without causing the chronic debilitating consequences.
15:26So let's summarize the central insight. Disruption of the PIK 5 complex is not simply a passive failure. It actively and rapidly engages a ULK1 dependent signaling cascade. This cascade fundamentally switches the lysosomal lipid signature from PI3K5P to PI4P, thereby coordinating simultaneous adaptive mechanisms for powerful lysosomal membrane repair and enhanced mitochondrial function.
15:52This pathway reveals a key cellular stress response. This leads to our final provocative thought for you. What does understanding this precise adaptive response mean for finding the optimal therapeutic window, that precise balance point, that captures the powerful protective benefits of acute PIK 5 inhibition without causing the system burnout and degenerative effects associated with sustained genetic loss of function?
16:14This is a question that will drive neurodegeneration research for years to come. This episode was based on an open access article under the CCBY 4.0 license. You can find a direct link to the paper and the license in our episode description.
16:27If you enjoyed this, follow or subscribe in your podcast app and leave a five-star rating. If you'd like to support our work, use the donation link in the description. Now stay with us for an original track created especially for this episode and inspired by the article you've just heard about.
16:42Thanks for listening and join us next time as we explore more science base by base.
